CD226 Antikörper (AA 307-335)
Kurzübersicht für CD226 Antikörper (AA 307-335) (ABIN1814148)
Target
Alle CD226 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 307-335
-
Spezifität
- This CD226 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 307-335 amino acids from the C-terminal region of human CD226.
-
Aufreinigung
- Protein A purified
-
-
-
-
Applikationshinweise
- Approved: WB (1:1000)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, 0.09 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
-
Haltbarkeit
- 6 months
-
-
- CD226
-
Andere Bezeichnung
- DNAM-1 / CD226
-
Hintergrund
-
Name/Gene ID: CD226
Synonyms: CD226, Adhesion glycoprotein, CD226 Molecule, CD226 antigen, DNAM-1, DNAM1, DNAX accessory molecule-1, TLiSA1, PTA1, DNAX accessory molecule 1 -
Gen-ID
- 10666
-
UniProt
- Q15762
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Target
-